|
Real-time Estimate
Tradegate
03:10:09 2026-11-03 EST
|
5-day change | 1st Jan Change | ||
| 74.10 EUR | -2.37% |
|
-1.43% | +16.59% |
| 10-30 | Redcare Pharmacy NV : Deutsche Bank reaffirms its Buy rating | ZD |
| 10-30 | Redcare Pharmacy NV : Gets a Buy rating from Berenberg | ZD |
| Market Cap | 1.56B 1.75B 1.43B 1.3B 2.44B 166B 2.49B 17.12B 6.9B 87.42B 6.57B 6.43B 276B | P/E 2026 * |
-243x | P/E 2027 * | 62.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.81B 2.02B 1.66B 1.51B 2.83B 192B 2.88B 19.81B 7.99B 101B 7.6B 7.44B 320B | EV / Sales 2026 * |
0.52x | EV / Sales 2027 * | 0.46x |
| Free-Float |
79.03% | Yield 2026 * |
0.09% | Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| RDC | Delayed | |
Boerse Muenchen
| RDC | Real-time | |
|
Tradegate
| RDC | Real-time | |
|
Börse Stuttgart
| RDC | Delayed | |
|
Swiss Exchange
| RDC | Delayed | |
|
Deutsche Boerse AG
| RDC | Delayed | |
|
Wiener Boerse
| SHOP | End-of-day quote | |
|
CBOE
| SAEd | Real-time | |
|
London S.E.
| 0RJT | Delayed | |
|
CBOE
| 0RJT | Real-time | |
|
Borsa Italiana
| 1RDC | End-of-day quote |
Last Transcript: Redcare Pharmacy NV
| 1 day | -2.34% | ||
| 1 week | -1.43% | ||
| Current month | +9.05% | ||
| 1 month | +8.04% | ||
| 3 months | +23.62% | ||
| 6 months | +56.82% | ||
| Current year | +16.59% |
| 1 week | 69.05 |  | 79.5 |
| 1 month | 65.45 | | 79.9 |
| Current year | 30.2 | | 79.9 |
| 1 year | 30.2 | | 79.9 |
| 3 years | 30.2 | | 171.4 |
| 5 years | 30.2 | | 171.4 |
| 10 years | 24 | | 249 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2026-09-30 | |
Hendrik Krampe
DFI | Director of Finance/CFO | - | 2025-11-30 |
Lode Fastré
CTO | Chief Tech/Sci/R&D Officer | - | 2024-04-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Köhler
CHM | Chairman | 62 | 2026-04-15 |
Stephan Weber
BRD | Director/Board Member | - | 2025-05-14 |
Anja Hendel
BRD | Director/Board Member | 48 | 2026-04-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/19/25 | Buy | Chairman | 2,000 | 0.0097% | ||
| 11/17/25 | Buy | Chairman | 2,000 | 0.0097% | ||
| 10/23/25 | Sell | Chief Operating Officer | 600 | 0.0029% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.37% | -1.43% | +6.83% | -31.96% | 1.75B | |
| +1.67% | +8.03% | -35.32% | +7.22% | 16.04B | |
| +0.75% | -1.26% | -6.05% | -0.76% | 6.54B | |
| +1.81% | +1.13% | -14.96% | +2.87% | 6.55B | |
| +2.43% | +5.56% | -49.66% | -39.15% | 5.92B | |
| -1.81% | -3.12% | -22.38% | -37.48% | 4.89B | |
| +0.68% | +4.35% | +9.09% | -7.29% | 4.86B | |
| +1.43% | +8.16% | +12.42% | -15.74% | 3.52B | |
| -0.05% | +9.77% | -21.08% | -32.09% | 3.15B | |
| +0.61% | +3.88% | -21.12% | +28.97% | 3.1B | |
| Average | +0.52% | +0.31% | -14.22% | -12.54% | 5.63B | |
| Weighted average by Cap. | +0.97% | +0.77% | -20.24% | -7.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.46B 3.87B 3.17B 2.89B 5.41B 367B 5.52B 37.92B 15.28B 194B 14.54B 14.23B 612B | 3.87B 4.33B 3.55B 3.23B 6.05B 410B 6.17B 42.38B 17.08B 216B 16.25B 15.91B 684B |
| Net income | -4.29M -4.8M -3.93M -3.58M -6.71M -455M -6.84M -46.98M -18.94M -240M -18.02M -17.63M -758M | 29.35M 32.87M 26.93M 24.5M 45.93M 3.11B 46.85M 322M 130M 1.64B 123M 121M 5.19B |
| Net Debt | 245M 275M 225M 205M 384M 26.03B 392M 2.69B 1.08B 13.74B 1.03B 1.01B 43.39B | 231M 258M 212M 192M 361M 24.45B 368M 2.53B 1.02B 12.9B 969M 948M 40.75B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-02 | €75.90 | +9.05% | 85,722 |
| 26-10-30 | €69.60 | -6.33% | 112,887 |
| 26-10-29 | €74.30 | -6.25% | 115,866 |
| 26-10-28 | €79.25 | +1.67% | 51,821 |
| 26-10-27 | €77.95 | +1.23% | 55,674 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RDC Stock
Select your edition
All financial news and data tailored to specific country editions
